These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17718861)

  • 1. Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC.
    Roncari B; Pedroni M; Maffei S; Di Gregorio C; Ponti G; Scarselli A; Losi L; Benatti P; Roncucci L; De Gaetani C; Camellini L; Lucci-Cordisco E; Tricarico R; Genuardi M; Ponz de Leon M
    Clin Genet; 2007 Sep; 72(3):230-7. PubMed ID: 17718861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.
    Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK;
    Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
    Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
    Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
    Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
    Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer.
    Ponti G; Losi L; Pellacani G; Wannesson L; Cesinaro AM; Venesio T; Petti C; Seidenari S
    Br J Dermatol; 2008 Jul; 159(1):162-8. PubMed ID: 18460031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recognising hereditary non-polyposis colorectal cancer without a clear family history].
    de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
    Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
    Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Need of new clinical criteria for the identification of genetic Lynch syndrome].
    Sousa R; Lage P; Ferreira S; Claro I; Francisco I; Filipe B; Albuquerque C; Suspiro A; Rodrigues P; Nobre-Leitão C
    Acta Med Port; 2007; 20(6):535-42. PubMed ID: 18331697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSH6 germline mutations are rare in colorectal cancer families.
    Peterlongo P; Nafa K; Lerman GS; Glogowski E; Shia J; Ye TZ; Markowitz AJ; Guillem JG; Kolachana P; Boyd JA; Offit K; Ellis NA
    Int J Cancer; 2003 Nov; 107(4):571-9. PubMed ID: 14520694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
    Ripa RS; Katballe N; Wikman FP; Jäger AC; Bernstein I; Orntoft T; Schwartz M; Nielsen FC; Bisgaard ML
    Mutat Res; 2005 Feb; 570(1):89-96. PubMed ID: 15680406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
    Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
    Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
    J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
    Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
    J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.